Fernando Hellmann, professor in the Department of Public Health at the Federal University of Santa Catarina: “Brazil faces the threat of a dengue epidemic of unprecedented proportions, challenging historical records since the disease was first reported in the country in the mid-19th century. The years 2022 and 2023 have already set records, with more than one million cases each, setting an alarming precedent for 2024. By the fourth epidemiological week of 2024, 243,721 probable cases of dengue have been confirmed, surpassing the total annual cases of the previous years by January, with more than a thousand deaths confirmed again. Furthermore, the increase in Chikungunya cases…”
Complete editions of the Latin America Advisor are delivered on a biweekly basis to members of the Dialogue’s Corporate Program and other subscribers. Sign up below for a free complimentary preview subscription.
Gene Kuleta
Editor
P. 202.463.2920
E. gkuleta@thedialogue.org
Carl David
Goette-Luciak
Reporter
Nili Blanck
Reporter
Diego Arria
Director,
Columbus Group
Merike Blofield
Professor of Political Science,
University of Hamburg
Devry Boughner Vorwerk
CEO,
DevryBV Sustainable Strategies
Joyce Chang
Global Head of Research,
J.P. Morgan
Marlene Fernández
Corporate Vice President for Gov’t Relations,
Arcos Dorados (McDonald’s)
Peter Hakim
President Emeritus,
Inter-American Dialogue
Donna Hrinak
Director,
Adtalem Global Education
Jon E. Huenemann
Council Member,
GLG Inc.
James R. Jones
Chairman,
Monarch Global Strategies
Craig Kelly
Senior Director,
Int’l Gov’t Relations,
Exxon Mobil
Barbara Kotschwar
Professor of Political Economy,
Georgetown University
John Maisto
Director,
US Education Finance Group
Nicolas Mariscal
Chairman,
Grupo Marhnos
Thomas F. McLarty III
Chairman,
McLarty Associates
Beatrice Rangel
Director,
AMLA Consulting
Ernesto Revilla
Head of Latin American Economics, Citi
Gustavo Roosen
President,
IESA
Andrés Rozental
President, Rozental &
Asociados
Shelly Shetty
Managing Director,
Sovereigns, Fitch
Inter-American Dialogue
1155 15th Street NW | Suite 800
Washington, DC 20005
P: +1-202-822-9002
F: +1-202-822-9553